Mixed chimerism and graft loss in pediatric recipients of an Alemtuzumab-based reduced-intensity conditioning regimen for non-malignant disease

Benjamin R. Oshrine, Timothy S. Olson, Nancy Bunin

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Mixed chimerism and graft loss in pediatric recipients of an Alemtuzumab-based reduced-intensity conditioning regimen for non-malignant disease'. Together they form a unique fingerprint.

Medicine & Life Sciences